LOwer Maintenance Dose TICagrelor in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention

NCT04060914 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

225

Enrollment

OTHER

Sponsor class

Conditions

Antiplatelet Therapy
Coronary Artery Disease
Percutaneous Coronary Intervention

Interventions

DRUG: Ticagrelor 90mg
DRUG: Ticagrelor 90mg/60mg
DRUG: Clopidogrel 75mg

Sponsor

Beijing Anzhen Hospital